Year archive

AprilBio Co.,Ltd. — 2022 filings

All 25 regulatory filings released by AprilBio Co.,Ltd. (397030) in 2022, sourced directly from the official regulator.

25 Filings

2022 Period

2022 filings (25)

Filing	Released	Lang
주주명부폐쇄기간또는기준일설정 Regulatory Filings	2022-12-14	Korean
기업설명회(IR)개최 Report Publication Announcement	2022-11-25	Korean
분기보고서 (2022.09) Interim / Quarterly Report 9M 2022	2022-11-10	Korean
기업설명회(IR)개최 Report Publication Announcement	2022-11-10	Korean
투자판단관련주요경영사항(자가염증질환 치료제 APB-R3 제1상 임상시험계획(IND) 승인) Regulatory Filings	2022-09-16	Korean
주식등의대량보유상황보고서(약식) Major Shareholding Notification	2022-09-13	Korean
주식등의대량보유상황보고서(약식) Major Shareholding Notification	2022-08-25	Korean
투자판단관련주요경영사항(SAFA 기반 융합단백질 기술라이선스 및 공동연구개발 계약 체결) Regulatory Filings	2022-08-19	Korean
투자판단관련주요경영사항(자가염증질환 치료제 APB-R3 제1상 임상시험계획(IND) 신청) Regulatory Filings	2022-08-17	Korean
주식등의대량보유상황보고서(약식) Major Shareholding Notification	2022-08-04	Korean
주식등의대량보유상황보고서(약식) Major Shareholding Notification	2022-08-04	Korean
주식등의대량보유상황보고서(약식) Major Shareholding Notification	2022-08-03	Korean
주식등의대량보유상황보고서(약식) Major Shareholding Notification	2022-08-03	Korean
주식등의대량보유상황보고서(일반) Major Shareholding Notification	2022-08-02	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2022-08-02	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Major Shareholding Notification	2022-07-29	Korean
주식등의대량보유상황보고서(약식) Major Shareholding Notification	2022-07-28	Korean
증권발행실적보고서 Share Issue/Capital Change	2022-07-22	Korean
[발행조건확정]증권신고서(지분증권) Share Issue/Capital Change	2022-07-18	Korean
[기재정정]투자설명서 Capital/Financing Update	2022-07-18	Korean
투자설명서 Capital/Financing Update	2022-07-12	Korean
[기재정정]증권신고서(지분증권) Capital/Financing Update	2022-07-11	Korean
[기재정정]증권신고서(지분증권) Capital/Financing Update	2022-07-07	Korean
증권신고서(지분증권) Share Issue/Capital Change	2022-06-20	Korean
감사보고서 (2021.12) Audit Report / Information FY 2021	2022-04-01	Korean